CCO Infectious Disease Podcast

Answering the Questions on HIV PrEP Persistence

Episode Summary

Hear from expert faculty as they discuss questions about HIV PrEP persistence, including strategies for helping people remain on PrEP when appropriate, considerations for switching PrEP regimens, and data around HIV incidence following PrEP discontinuation.

Episode Notes

In this episode, Darrell H. S. Tan, MD, FRCPC, PhD, and Kenric Ware, PharmD, AAHIVP, discuss considerations for HIV pre-exposure prophylaxis (PrEP) persistence, including:

• The PrEP continuum of care in the United States, including inequities in PrEP uptake and persistence by race
• CDC PrEP guidance regarding PrEP indications
• PrEP eligibility by regimen
• Summary of renal, bone, and weight outcomes with different PrEP options
• Data on HIV acquisition following PrEP discontinuation
• Drug concentrations and recommendations for stopping long-acting cabotegravir for PrEP
• Expanding PrEP options to facilitate adherence and persistence
• Providing PrEP by telehealth

Presenters:

Darrell H. S. Tan, MD, FRCPC, PhD
Associate Professor
Division of Infectious Diseases
University of Toronto
Clinician-Scientist
Division of Infectious Diseases
St. Michael’s Hospital
Toronto, Canada

Kenric Ware, PharmD, AAHIVP
Associate Professor
Department of Pharmacy Practice
South University
Savannah, Georgia
Chairperson, Pharmacist
Board of Directors
Joseph H. Neal Health Collaborative
Columbia, South Carolina

Link to full program:
https://bit.ly/3HPu4Lk